Analysts/Institutional Investor Meet/Con. Call Updates

Date: 22nd September 2026 National Stock Exchange of India Limited BSE Limited Phiroze Jeejeebhoy Towers Dalal Exchange Plaza, C-1, Block G Bandra Kurla Street, Mumbai – 400001 Complex, Bandra (E), Mumbai – 400051 Scrip Code: 544619 Scrip Symbol- SUDEEPPHRM Sub: Cancellation of Schedule of Analyst / Investor Plant Visit Ref: Regulation 30 of the SEBI Listing Regulations, 2015 Dear Sir/Madam, This is with reference to our letter dated 16th September 2026, we would like to inform you that the Analysts / Investors Plant Visit scheduled on 23rd and 24th September 2026, from 11:00 AM IST onwards has been CANCELLED due to some exigencies. This is for your information and for the information of your members and the public at large. This information is submitted to you pursuant to Regulation 30 (6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Thanking You. For Sudeep Pharma Limited Dimple Mehta Company Secretary & Compliance Officer M. No.: F13184 CIN: L24231GJ1989PLC013141 Registered Office: 129/1/A, G.I.D.C. Estate Nandesari, Baroda-391340, Gujarat, India. Phone No.: +91 265 2840656, 7624095107 Corporate Office: 601, 602, 6th Floor, Sears Towers-2, Gotri-Sevasi Road, Sevasi, Vadodara-390021, Gujarat, India Website: www.sudeepgroup.com, Email ID: mail@sudeepgroup.com